Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Immunomic Therapeutics and Annias enter license agreement for cancer immunotherapy technology

May 16, 2017

Biogen acquires Cirara from Remedy Pharmaceuticals

May 16, 2017

Otsuka and Teva enter licensing agreement for fremanezumab in Japan

May 16, 2017

Seikagaku and Ono enter codevelopment and marketing collaboration on SI-613

May 15, 2017

EpiThany, Merck KGaA and Pfizer to evaluate avelumab in combination with EP-101 in breast cancer

May 12, 2017

Sangamo and Pfizer collaborate on gene therapy programs for hemophilia A

May 11, 2017

Companies partner on E.U. managed access programs for niraparib and belinostat

May 11, 2017

Vericel's ixmyelocel-T wins FDA regenerative medicine advanced therapy designation

May 11, 2017

Takeda and GammaDelta Therapeutics announce strategic collaboration

May 11, 2017

Pharnext and Tasly enter strategic agreement

May 10, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...